Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamisole Combined With Cyclosporine A in PNH
NCT01642979Phase 2Unknown
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jul 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of levamisole in paroxysmal nocturnal hemoglobinuria (PNH) (3 arms), sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoint: Number of patients in each group in complete or partial remission at 6 months. Status: unknown.
02
Drugs
levamisole
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT01642979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642979.